Colella G, Bonfanti M, D'Incalci M, Broggini M
Molecular Pharmacology Unit, LCP, Department of Oncology, Istituto di Richerche Farmacologiche Mario Negri, Milan, Italy.
Nucleic Acids Res. 1996 Nov 1;24(21):4227-33. doi: 10.1093/nar/24.21.4227.
By using electromobility shift assay (EMSA), we have identified a protein able to recognize the DNA only if it was previously reacted with minor groove binders. This protein binds with very high affinity AT containing DNA treated with minor groove binders such as distamycin A, Hoechst 33258 and 33342, CC-1065 and ethidium bromide minor groove intercalator, but not with major groove binders such as quinacrine mustard, cisplatin or melphalan, or with topoisomerase I inhibitor camptothecin or topoisomerase II inhibitor doxorubicin. This protein was found to be present in different extracts of human, murine and hamster cells, with the human protein which appears to have a molecular weight slightly lower than that of the other species. This protein was found to be expressed both in cancer and normal tissues. By using molecular ultrafiltration techniques as well as southwestern analysis it was estimated that the apparent molecular weight is close to 100 kDa. We can exclude an identity between this protein and other proteins, with a similar molecular weight previously reported to be involved in DNA damage recognition/repair, such as topoisomerase I, mismatch repair activities such as the prokaryotic MutS protein and its human homologue hMSH2 or proteins of the nucleotide excision repair system such as ERCC1, -2, -3 and -4.
通过使用电泳迁移率变动分析(EMSA),我们鉴定出一种蛋白质,该蛋白质只有在与小沟结合剂预先反应后才能识别DNA。这种蛋白质以非常高的亲和力结合用小沟结合剂处理过的含AT的DNA,如偏端霉素A、Hoechst 33258和33342、CC-1065以及溴化乙锭小沟嵌入剂,但不与大沟结合剂如喹吖因氮芥、顺铂或美法仑结合,也不与拓扑异构酶I抑制剂喜树碱或拓扑异构酶II抑制剂阿霉素结合。发现这种蛋白质存在于人类、小鼠和仓鼠细胞的不同提取物中,其中人类蛋白质的分子量似乎略低于其他物种。发现这种蛋白质在癌症组织和正常组织中均有表达。通过使用分子超滤技术以及蛋白质印迹分析,估计其表观分子量接近100 kDa。我们可以排除该蛋白质与其他蛋白质的同一性,这些蛋白质分子量相似,先前报道参与DNA损伤识别/修复,如拓扑异构酶I、错配修复活性如原核MutS蛋白及其人类同源物hMSH2或核苷酸切除修复系统的蛋白质如ERCC1、-2、-3和-4。